Related Experiment Videos
Piezoelectric immunoassay for complement C4 based on a Nafion-modified interface for antibody immobilization
Ting Deng1, Ji-Shan Li, Hua Wang
1State Key Laboratory of Chem/Biosensing and Chemometrics, Chemistry and Chemical Engineering College, Hunan University, Changsha 410082, China.
Journal of Immunological Methods
|May 26, 2005
Summary
A novel piezoelectric immunosensor using Nafion membrane efficiently detects complement C4 in human serum. This simple, rapid method offers a promising tool for clinical diagnosis of complement C4 levels.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Materials Science
Background:
- Complement C4 (C4) is a crucial component of the immune system.
- Accurate determination of C4 levels is vital for diagnosing various diseases.
- Existing C4 detection methods can be complex and time-consuming.
Purpose of the Study:
- To develop a simple, rapid, and sensitive piezoelectric immunosensor for C4 determination.
- To utilize Nafion membrane for efficient antibody immobilization on a quartz-crystal microbalance (QCM).
- To evaluate the performance of the developed immunosensor for C4 detection in human serum.
Main Methods:
- Fabrication of a piezoelectric immunosensor using a Nafion membrane on a QCM electrode.
- Immobilization of anti-C4 antibodies onto the Nafion-modified QCM surface.
- Optimization of immunosensor preparation and assay parameters.
- Characterization of the modified surface using scanning electron microscopy (SEM).
Main Results:
- The immunosensor demonstrated a good response to C4 within the range of 0.08-1.6 µg/ml.
- The method achieved a low relative standard deviation of <5.3%.
- The immunosensor exhibited simple immobilization, rapid assay, and efficient regeneration processes.
Conclusions:
- The developed Nafion-based piezoelectric immunosensor is a sensitive and reliable tool for C4 detection.
- The simple and efficient nature of the sensor makes it suitable for clinical diagnosis.
- This approach offers a promising alternative for the clinical assessment of complement C4.